Brussels-based Ageas said the deal could generate at least £100 million in cost savings for the insurer per year, according to a statement on Monday. The transaction, which is subject to regulatory approval, is expected to close in the second half of 2025. Shares in Ageas were trading up 1.8% as of 11:30 a.m. in Brussels.
Monday’s deal comes just over a year after Ageas’s failed takeover attempt ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.